MABC567 Sigma-AldrichAnti-Somatoliberin/GHRH Antibody, clone 1B4.2
This Anti-Somatoliberin Antibody, clone 1B4.2 is validated for use in Western Blotting and Immunohistochemistry (Paraffin) for the detection of GHRH .
More>> This Anti-Somatoliberin Antibody, clone 1B4.2 is validated for use in Western Blotting and Immunohistochemistry (Paraffin) for the detection of GHRH . Less<<Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| Species Reactivity | Key Applications | Host | Format | Antibody Type |
|---|---|---|---|---|
| H | WB, IH(P) | M | Purified | Monoclonal Antibody |
| References |
|---|
| Product Information | |
|---|---|
| Format | Purified |
| Presentation | Purified mouse monoclonal IgG1κ antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide. |
| Quality Level | MQ100 |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Storage and Shipping Information | |
|---|---|
| Storage Conditions | Stable for 1 year at 2-8°C from date of receipt. |
| Packaging Information | |
|---|---|
| Material Size | 100 μg |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| MABC567 | 04055977175325 |
Documentation
Anti-Somatoliberin/GHRH Antibody, clone 1B4.2 SDS
| Title |
|---|
Anti-Somatoliberin/GHRH Antibody, clone 1B4.2 Certificates of Analysis
| Title | Lot Number |
|---|---|
| Anti-Somatoliberin/GHRH, clone 1B4.2 - 3327581 | 3327581 |
| Anti-Somatoliberin/GHRH, clone 1B4.2 - 3792019 | 3792019 |
| Anti-Somatoliberin/GHRH, clone 1B4.2 - 4136260 | 4136260 |
| Anti-Somatoliberin/GHRH, clone 1B4.2 -Q2578153 | Q2578153 |
Technical Info
| Title |
|---|
| Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System |
| White Paper: Further considerations of antibody validation and usage. |



